Glucocorticoids increase α5 integrin expression and adhesion of synovial fibroblasts but inhibit ERK signaling, migration, and cartilage invasion

Arthritis and Rheumatism

Volumn 60, Issue 12, 2009, Pages 3623-3632

  Lowin, Torsten ^a   Straub, Rainer H ^a   Neumann, Elena ^b   Bosserhoff, Anja ^a   Vogel, Corinna ^a   Moissl, Christine ^a   Anders, Sven ^a   Müller Ladner, Ulf ^b   Schedel, Jörg ^c  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; BETA1 INTEGRIN; CD51 ANTIGEN; CYTOKINE; ESTRADIOL; FIBRONECTIN; GLUCOCORTICOID; GROWTH FACTOR; HYDROCORTISONE; INTEGRIN; METHOTREXATE; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE; SMALL INTERFERING RNA; STEROID; TESTOSTERONE; TUMOR NECROSIS FACTOR;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARTILAGE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; SCID MOUSE; SIGNAL TRANSDUCTION; SYNOVIOCYTE; UPREGULATION; ANIMAL; ARTICULAR CARTILAGE; CELL CULTURE; CELL MOTION; DRUG ANTAGONISM; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY; RNA INTERFERENCE; SYNOVIUM;

AGED; ANIMALS; ANTIBODIES, NEUTRALIZING; CARTILAGE, ARTICULAR; CELL MOVEMENT; CELLS, CULTURED; ESTRADIOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FIBROBLASTS; GENE EXPRESSION; HUMANS; HYDROCORTISONE; INTEGRIN ALPHA5; MALE; MICE; MICE, SCID; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; TESTOSTERONE;

EID: 73249138225     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24985     Document Type: Article

References (58)

1. Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors? Arthritis Rheum 1996;39:1781-90.
2. Gitter BD, Labus JM, Lees SL, Scheetz ME. Characteristics of human synovial fibroblast activation by IL-1β and TNFα. Immunology 1989;66:196-200.
3. Lafyatis R, Remmers EF, Roberts AB, Yocum DE, Sporn MB, Wilder RL. Anchorage-independent growth of synoviocytes from arthritic and normal joints: stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-β and retinoids. J Clin Invest 1989;83:1267-76.
4. Case JP, Lafyatis R, Remmers EF, Kumkumian GK, Wilder RL. Transin/stromelysin expression in rheumatoid synovium: a transformation- associated metalloproteinase secreted by phenotypically invasive synoviocytes. Am J Pathol 1989;135:1055-64.
5. Kirwan JR, for The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995;333:142-6.
6. Van Everdingen AA, Jacobs JW, Siewertsz van Reesema DR, Bijlsma JW. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 2002;136:1-12.
7. Chikanza IC, Grossman AB. Reciprocal interactions between the neuroendocrine and immune systems during inflammation. Rheum Dis Clin North Am 2000;26:693-711.
8. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 1995;270:286-90.
9. Bruna A, Nicolas M, Munoz A, Kyriakis JM, Caelles C. Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids. EMBO J 2003;22:6035-44.
10. Caelles C, Gonzalez-Sancho JM, Munoz A. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev 1997;11:3351-64.
11. Straub RH, Paimela L, Peltomaa R, Scholmerich J, Leirisalo-Repo M. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum 2002;46:654-62.
12. Schmidt M, Weidler C, Naumann H, Anders S, Scholmerich J, Straub RH. Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: possible role of the sympathetic nervous system? Arthritis Rheum 2005;52:1711-20.
13. Brakebusch C, Bouvard D, Stanchi F, Sakai T, Fassler R. Integrins in invasive growth. J Clin Invest 2002;109:999-1006.
14. Burridge K, Chrzanowska-Wodnicka M. Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 1996;12:463-518.
15. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999;285: 1028-32.
16. Zhang Z, Tarone G, Turner DC. Expression of integrin α1 β1 is regulated by nerve growth factor and dexamethasone in PC12 cells: functional consequences for adhesion and neurite outgrowth. J Biol Chem 1993;268:5557-65.
17. Dickerson JE Jr, Steely HT Jr, English-Wright SL, Clark AF. The effect of dexamethasone on integrin and laminin expression in cultured human trabecular meshwork cells. Exp Eye Res 1998;66: 731-8.
18. Zoppi N, Ghinelli A, Gardella R, Barlati S, Colombi M. Effect of dexamethasone on the assembly of the matrix of fibronectin and on its receptors organization in Ehlers-Danlos syndrome skin fibroblasts. Cell Biol Int 1998;22:499-508.
19. Moschos SJ, Drogowski LM, Reppert SL, Kirkwood JM. Integrins and cancer. Oncology (Williston Park) 2007;21:13-20.
20. Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996;149:1607-15.
21. Rinaldi N, Schwarz-Eywill M, Weis D, Leppelmann-Jansen P, Lukoschek M, Keilholz U, et al. Increased expression of integrins on fibroblast-like synoviocytes from rheumatoid arthritis in vitro correlates with enhanced binding to extracellular matrix proteins. Ann Rheum Dis 1997;56:45-51.
22. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
23. Miller LE, Justen HP, Scholmerich J, Straub RH. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J 2000;14:2097-107.
24. Goodwin AE, Pauli BU. A new adhesion assay using buoyancy to remove non-adherent cells. J Immunol Methods 1995;187:213-9.
25. Neumann E, Barnum SR, Tarner IH, Echols J, Fleck M, Judex M, et al. Local production of complement proteins in rheumatoid arthritis synovium. Arthritis Rheum 2002;46:934-45.
26. Massoumi R, Kuphal S, Hellerbrand C, Haas B, Wild P, Spruss T, et al. Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma. J Exp Med 2009;206: 221-32.
27. Rinaldi N, Weis D, Brado B, Schwarz-Eywill M, Lukoschek M, Pezzutto A, et al. Differential expression and functional behaviour of the αv and β3 integrin subunits in cytokine stimulated fibroblast-like cells derived from synovial tissue of rheumatoid arthritis and osteoarthritis in vitro. Ann Rheum Dis 1997;56:729-36.
28. Pirila L, Aho H, Roivainen A, Konttinen YT, Pelliniemi LJ, Heino J. Identification of α6β1 integrin positive cells in synovial lining layer as type B synoviocytes. J Rheumatol 2001;28:478-84.
29. Kitagawa A, Miura Y, Saura R, Mitani M, Ishikawa H, Hashiramoto A, et al. Anchorage on fibronectin via VLA-5 (α5β1 integrin) protects rheumatoid synovial cells from Fas-induced apoptosis. Ann Rheum Dis 2006;65:721-7.
30. Scott DL, Wainwright AC, Walton KW, Williamson N. Significance of fibronectin in rheumatoid arthritis and osteoarthrosis. Ann Rheum Dis 1981;40:142-53.
31. Sarkissian M, Lafyatis R. Integrin engagement regulates proliferation and collagenase expression of rheumatoid synovial fibroblasts. J Immunol 1999;162:1772-9.
32. Chen Q, Manning CD, Millar H, McCabe FL, Ferrante C, Sharp C, et al. CNTO 95, a fully human anti αv integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells. Clin Exp Metastasis 2008;25:139-48.
33. Wang AZ, Wang JC, Fisher GW, Diamond HS. Interleukin-1β-stimulated invasion of articular cartilage by rheumatoid synovial fibroblasts is inhibited by antibodies to specific integrin receptors and by collagenase inhibitors. Arthritis Rheum 1997;40: 1298-307.
34. Pirila L, Heino J. Altered integrin expression in rheumatoid synovial lining type B cells: in vitro cytokine regulation of α1 β1, α6 β1, and αv β5 integrins. J Rheumatol 1996;23:1691-8.
35. Gailit J, Xu J, Bueller H, Clark RA. Platelet-derived growth factor and inflammatory cytokines have differential effects on the expression of integrins α1 β1 and α5 β1 by human dermal fibroblasts in vitro. J Cell Physiol 1996;169:281-9.
36. Fukushima Y, Ohnishi T, Arita N, Hayakawa T, Sekiguchi K. Integrin α3β1-mediated interaction with laminin-5 stimulates adhesion, migration and invasion of malignant glioma cells. Int J Cancer 1998;76:63-72.
37. Ura H, Denno R, Hirata K, Yamaguchi K, Yasoshima T. Separate functions of α2β1 and α3β1 integrins in the metastatic process of human gastric carcinoma. Surg Today 1998;28:1001-6.
38. Sugiura T, Berditchevski F. Function of α3β1-tetraspanin protein complexes in tumor cell invasion: evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2). J Cell Biol 1999;146:1375-89.
39. Iyer V, Pumiglia K, DiPersio CM. α3β1 integrin regulates MMP-9 mRNA stability in immortalized keratinocytes: a novel mechanism of integrin-mediated MMP gene expression. J Cell Sci 2005;118: 1185-95.
40. Yao ES, Zhang H, Chen YY, Lee B, Chew K, Moore D, et al. Increased β1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res 2007;67:659-64.
41. Kim YH, Jun JH, Woo KM, Ryoo HM, Kim GS, Baek JH. Dexamethasone inhibits the formation of multinucleated osteoclasts via down-regulation of β3 integrin expression. Arch Pharm Res 2006;29:691-8.
42. Varner JA, Emerson DA, Juliano RL. Integrin α5 β1 expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol Biol Cell 1995;6:725-40.
43. Bhaskar V, Fox M, Breinberg D, Wong MH, Wales PE, Rhodes S, et al. Volociximab, a chimeric integrin α5β1 antibody, inhibits the growth of VX2 tumors in rabbits. Invest New Drugs 2008;26:7-12.
44. Adachi M, Taki T, Higashiyama M, Kohno N, Inufusa H, Miyake M. Significance of integrin α5 gene expression as a prognostic factor in node-negative non-small cell lung cancer. Clin Cancer Res 2000;6:96-101.
45. Zhang Z, Vuori K, Reed JC, Ruoslahti E. The α5β1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci U S A 1995;92:6161-5.
46. Murthy MS, Reid S Jr, Yang XF, Scanlon EP. The potential role of integrin receptor subunits in the formation of local recurrence and distant metastasis by mouse breast cancer cells. J Surg Oncol 1996;63:77-86.
47. Ly DP, Corbett SA. The integrin α5β1 regulates αvβ3-mediated extracellular signal-regulated kinase activation. J Surg Res 2005; 123:200-5.
48. Ly DP, Zazzali KM, Corbett SA. De novo expression of the integrin α5β1 regulates αvβ3-mediated adhesion and migration on fibrinogen. J Biol Chem 2003;278:21878-85.
49. Schedel J, Wenglen C, Distler O, Muller-Ladner U, Scholmerich J, Heinegard D, et al. Differential adherence of osteoarthritis and rheumatoid arthritis synovial fibroblasts to cartilage and bone matrix proteins and its implication for osteoarthritis pathogenesis. Scand J Immunol 2004;60:514-23.
50. Morin I, Li WQ, Su S, Ahmad M, Zafarullah M. Induction of stromelysin gene expression by tumor necrosis factor α is inhibited by dexamethasone, salicylate, and N-acetylcysteine in synovial fibroblasts. J Pharmacol Exp Ther 1999;289:1634-40.
51. Greenberg AK, Hu J, Basu S, Hay J, Reibman J, Yie TA, et al. Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators. Am J Respir Cell Mol Biol 2002;27:320-8.
52. Ramalingam A, Hirai A, Thompson EA. Glucocorticoid inhibition of fibroblast proliferation and regulation of the cyclin kinase inhibitor p21Cip1. Mol Endocrinol 1997;11:577-86.
53. Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M, Cato AC. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 2001;20:7108-16.
54. Caelles C, Bruna A, Morales M, Gonzalez-Sancho JM, Gonzalez MV, Jimenez B, et al. Glucocorticoid receptor antagonism of AP-1 activity by inhibition of MAPK family. Ernst Schering Res Found Workshop 2002;131-52.
55. Chen Q, Meng LH, Zhu CH, Lin LP, Lu H, Ding J. ADAM15 suppresses cell motility by driving integrin α5β1 cell surface expression via Erk inactivation. Int J Biochem Cell Biol 2008;40: 2164-73.
56. Arimoto-Ishida E, Sakata M, Sawada K, Nakayama M, Nishimoto F, Mabuchi S, et al. Up-regulation of α5-integrin by E-cadherin loss in hypoxia and its key role in the migration of extravillous trophoblast cells during early implantation. Endocrinology 2009; 150:4306-15.
57. Zeng ZZ, Yao H, Staszewski ED, Rockwood KF, Markwart SM, Fay KS, et al. α(5)β(1) integrin ligand PHSRN induces invasion and α(5) mRNA in endothelial cells to stimulate angiogenesis. Transl Oncol 2009;2:8-20.
58. Sawada K, Mitra AK, Radjabi AR, Bhaskar V, Kistner EO, Tretiakova M, et al. Loss of E-cadherin promotes ovarian cancer metastasis via α5-integrin, which is a therapeutic target. Cancer Res 2008;68:2329-39.